FUS (Myc-DDK-tagged)-Human fused in sarcoma (FUS), transcript variant 1
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
FUS (Myc-DDK-tagged)-Human fused in sarcoma (FUS), transcript variant 1
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
Fus (Myc-DDK-tagged) - Mouse fusion, derived from t(12,16) malignant liposarcoma (human) (Fus)
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
Lenti ORF particles, FUS (Myc-DDK tagged) - Human fused in sarcoma (FUS), transcript variant 1, 200ul, >10^7 TU/mL
Vector | pLenti-C-Myc-DDK |
Tag | Myc-DDK |
FUS (Myc-DDK-tagged)-Human fused in sarcoma (FUS), transcript variant 4. Note: ORF is codon optimized
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
FUS (Myc-DDK-tagged)-Human fused in sarcoma (FUS), transcript variant 3
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
Lenti ORF clone of Fus (Myc-DDK-tagged) - Mouse fusion, derived from t(12;16) malignant liposarcoma (human) (Fus)
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti ORF particles, Fus (Myc-DDK-tagged) - Mouse fusion, derived from t(12;16) malignant liposarcoma (human) (Fus), 200ul, >10^7 TU/mL
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti ORF clone of Human fused in sarcoma (FUS), transcript variant 1, Myc-DDK-tagged
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti ORF particles, FUS (Myc-DDK tagged) - Human fused in sarcoma (FUS), transcript variant 1, 200ul, >10^7 TU/mL
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti-ORF clone of FUS (Myc-DDK-tagged)-Human fused in sarcoma (FUS), transcript variant 4. Note: ORF is codon optimized
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti ORF particles, FUS (Myc-DDK-tagged)-Human fused in sarcoma (FUS), transcript variant 4, 200ul, >10^7 TU/mL. Note: ORF is codon optimized
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti-ORF clone of FUS (Myc-DDK-tagged)-Human fused in sarcoma (FUS), transcript variant 3
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti ORF particles, FUS (Myc-DDK-tagged)-Human fused in sarcoma (FUS), transcript variant 3, 200ul, >10^7 TU/mL
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Fus (Myc-DDK-tagged ORF) - Rat fusion, derived from t(12,16) malignant liposarcoma (human) (Fus), (10 ug)
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
Lenti ORF clone of Fus (Myc-DDK-tagged ORF) - Rat fusion, derived from t(12;16) malignant liposarcoma (human) (Fus), (10 ug)
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti ORF particles, Fus (Myc-DDK-tagged ORF) - Rat fusion, derived from t(12;16) malignant liposarcoma (human) (Fus), 200ul, >10^7 TU/mL
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti ORF clone of Human fused in sarcoma (FUS), transcript variant 1, Myc-DDK-tagged
Vector | pLenti-C-Myc-DDK |
Tag | Myc-DDK |
Mammalian Cell Selection | None |